We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+9.54%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$109B
AUM Growth
+$10.1B
Cap. Flow
+$2.06B
Cap. Flow %
1.89%
Top 10 Hldgs %
23.41%
Holding
4,156
New
227
Increased
1,649
Reduced
1,885
Closed
242

Sector Composition

Rank Sector Weight
1 Technology 12.51%
2 Healthcare 9.35%
3 Financials 9.21%
4 Industrials 6.82%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCSI icon
3201
Consensus Cloud Solutions
CCSI
$717M
$305K ﹤0.01%
5,671
-192
-3% -$10.5K
DNOW icon
3202
DNOW Inc
DNOW
$2.95B
$304K ﹤0.01%
23,929
-499
-2% -$6.05K
SRI icon
3203
Stoneridge
SRI
$201M
$303K ﹤0.01%
14,068
+1,565
+13% +$33.5K
SNPE icon
3204
Xtrackers S&P 500 ESG ETF
SNPE
$2.8B
$303K ﹤0.01%
8,765
-1,712
-16% -$59.5K
SDIV icon
3205
Global X SuperDividend ETF
SDIV
$1.21B
$302K ﹤0.01%
12,569
+296
+2% +$7.11K
BHC icon
3206
Bausch Health
BHC
$2.37B
$302K ﹤0.01%
48,081
-9,492
-16% -$66.3K
AM icon
3207
Antero Midstream
AM
$10.5B
$302K ﹤0.01%
27,960
+4,169
+18% +$44.2K
PRTA icon
3208
Prothena Corp
PRTA
$466M
$302K ﹤0.01%
+5,005
New +$293K
HPI
3209
John Hancock Preferred Income Fund
HPI
$433M
$301K ﹤0.01%
18,773
+870
+5% +$13.9K
TCOM icon
3210
Trip.com Group
TCOM
$28.3B
$301K ﹤0.01%
8,738
-45
-0.5% -$1.29K
ENZL icon
3211
iShares MSCI New Zealand ETF
ENZL
$82.7M
$300K ﹤0.01%
6,188
IWL icon
3212
iShares Russell Top 200 ETF
IWL
$2.29B
$300K ﹤0.01%
+3,335
New +$303K
PIO icon
3213
Invesco Global Water ETF
PIO
$278M
$300K ﹤0.01%
9,186
-4,862
-35% -$155K
FDIS icon
3214
Fidelity MSCI Consumer Discretionary Index ETF
FDIS
$1.72B
$300K ﹤0.01%
5,288
-12,835
-71% -$779K
IMO icon
3215
Imperial Oil
IMO
$64B
$299K ﹤0.01%
6,138
+85
+1% +$4.38K
LLY icon
3216
PUT
Eli Lilly
LLY
$1.08T
$298K ﹤0.01%
+5,500
New +$1.95M
IX icon
3217
ORIX
IX
$43.9B
$297K ﹤0.01%
18,465
+1,180
+7% +$17.9K
CSTR
3218
DELISTED
CapStar Financial Holdings, Inc
CSTR
$297K ﹤0.01%
16,834
PFBC icon
3219
Preferred Bank
PFBC
$1.28B
$296K ﹤0.01%
+3,968
New +$289K
NDMO icon
3220
Nuveen Dynamic Municipal Opportunities Fund
NDMO
$608M
$296K ﹤0.01%
29,736
+3,900
+15% +$39.6K
AMJ
3221
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$295K ﹤0.01%
13,549
-4,958
-27% -$109K
DOL icon
3222
WisdomTree True Developed International Fund
DOL
$848M
$295K ﹤0.01%
6,693
-239
-3% -$10K
DY icon
3223
Dycom Industries
DY
$12.3B
$294K ﹤0.01%
3,143
-2,477
-44% -$249K
BJUL icon
3224
Innovator US Equity Buffer ETF July
BJUL
$355M
$294K ﹤0.01%
9,502
-727
-7% -$22.4K
PDT
3225
John Hancock Premium Dividend Fund
PDT
$628M
$293K ﹤0.01%
22,641
-563
-2% -$7.64K

Similar funds

Raymond James & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Raymond James & Associates held 4,156 positions worth $109B, up 10% from $98.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Raymond James & Associates's Q4 2022 filing shows 227 new, 1,649 increased, 1,885 reduced and 242 closed positions. Its largest new stake was Rentokil: 285,133 shares worth $8.78M. The largest sale was iShares Expanded Tech Sector ETF, an estimated $79.2M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q4 2022 buy was Rentokil: 285,133 shares worth $8.78M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q4 2022, an estimated $169M increase.
  • Raymond James & Associates's biggest Q4 2022 reduction was iShares Expanded Tech Sector ETF, cutting an estimated $79.2M.
  • Raymond James & Associates fully exited Change Healthcare Inc. Common Stock in Q4 2022, selling an estimated $53.3M.
  • Raymond James & Associates's ten largest holdings make up 23% of its $109B portfolio in Q4 2022.
  • Raymond James & Associates opened 227 new positions and closed 242 in Q4 2022.
  • Raymond James & Associates's portfolio value rose 10% quarter-over-quarter to $109B.

Based on Raymond James & Associates's 13F filing for Q4 2022, filed 8 Feb 2023.